Peritoneoscintigraphy in detection of improper placement of peritoneal catheter into bowel lumen prior to chromic phosphate P-32 therapy. A case report.
Radionuclide peritoneoscintigraphy has been used prior to chromic phosphate P-32 (P-32CP) intraperitoneal therapy to assure proper placement of the catheter in the peritoneal cavity, to exclude loculation, and to predict inadequate distribution of P-32CP. This is a case report of the detection of a peritoneal catheter improperly placed into the bowel lumen by pretherapy radionuclide peritoneoscintigraphy, and this case demonstrates the distinguishing characteristics of the radiocolloid distribution secondary to an intraluminal injection relative to an intraperitoneal injection.
D000230:Adenocarcinoma / Q000532:radiotherapy; D001918:Brachytherapy; D002404:Catheterization / Q000009:adverse effects*; D002857:Chromium / Q000627:therapeutic use*; D017608:Chromium Compounds; D003110:Colonic Neoplasms / Q000532:radiotherapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D010529:Peritoneal Cavity / Q000000981:diagnostic imaging*; D010534:Peritoneal Neoplasms / Q000532:radiotherapy; D010710:Phosphates / Q000627:therapeutic use*; D010761:Phosphorus Radioisotopes / Q000627:therapeutic use*; D011877:Radionuclide Imaging; D013671:Technetium Tc 99m Sulfur Colloid
D017608:Chromium Compounds; D010710:Phosphates; D010761:Phosphorus Radioisotopes; D002857:Chromium; D013671:Technetium Tc 99m Sulfur Colloid; C509369:chromic phosphate